Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF SignalingXiwei Ji(Peking University), Xiao Zhu(Fudan University)International Journal of Molecular SciencesJanuary 1, 202310.3390/ijms24010757Cited by 4SaveCiteExport RISWatch citationsRelated PapersDopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells|Biochemical Pharmacology|2015|37Development and validation of a highly sensitive LC‐MS/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study|Biomedical Chromatography|2014|33